Literature DB >> 18810682

Global epidemiology of tuberculosis: prospects for control.

Knut Lönnroth1, Mario Raviglione.   

Abstract

The burden of tuberculosis (TB) is now very slowly decreasing globally. However, the rate of decline is too slow to reach all the epidemiological impact targets set for 2015. The prospects for reaching the TB elimination target set for 2050 are even bleaker. Implementation of the World Health Organization's Stop TB Strategy is currently lagging behind the envisioned scale-up pace, particularly with regard to TB/HIV collaborative activities and management of drug resistant TB. To ensure long-term TB control there is, first, a need to ensure that all components of the Stop TB Strategy are scaled up according to plans, with special attention to improved access for the poor. However, this may not be enough. Recent analyses suggest that the impact of current efforts to reduce TB incidence is less than expected and that improved diagnostic and curative efforts need to be combined with additional preventive efforts. New and more effective vaccines and drugs for preventive treatment would revolutionize TB control. A stronger focus on prevention would also entail more concerted actions to limit the impact of TB risk factors, including HIV/AIDS, smoking, malnutrition, alcoholism, diabetes, crowded living conditions, and indoor air pollution, which may all contribute a considerable proportion of the global TB burden.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18810682     DOI: 10.1055/s-0028-1085700

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  76 in total

1.  Knowledge, attitudes, and practice of tuberculosis among Maasai in Simanjiro district, Tanzania.

Authors:  Pieter Jacob Haasnoot; Tijs Evert Boeting; Moignet Ole Kuney; Jos van Roosmalen
Journal:  Am J Trop Med Hyg       Date:  2010-10       Impact factor: 2.345

2.  A smoking cessation intervention among tuberculosis patients in rural China.

Authors:  Y Lin; L-X Wang; L-X Qiu; Q Huang; Q Shu; H-X Lin; X Meng; X-L Zeng; L-X Xiao; T S Bam; C-Y Chiang
Journal:  Public Health Action       Date:  2015-09-21

3.  One-stage posterior focus debridement, interbody grafts, and posterior instrumentation and fusion in the surgical treatment of thoracolumbar spinal tuberculosis with kyphosis in children: a preliminary report.

Authors:  Yu-Xiang Wang; Hong-Qi Zhang; Ming-Xing Tang; Chao-Feng Guo; Ang Deng; Jian-Huang Wu; Jin-Yang Liu; Zhansheng Deng; Jing Chen
Journal:  Childs Nerv Syst       Date:  2016-07-08       Impact factor: 1.475

4.  Commentary: Socio-economic determinants of tuberculosis in Recife, Brazil.

Authors:  Suzanne Marks
Journal:  Int J Epidemiol       Date:  2009-08-31       Impact factor: 7.196

5.  Clinical and laboratory features of tuberculosis within a hospital population in Libreville, Gabon.

Authors:  D U Kombila; J-B Moussavou-Kombila; M P Grobusch; B Lell
Journal:  Infection       Date:  2012-12-13       Impact factor: 3.553

6.  Development and testing of models of tuberculosis contact tracing in rural southern Africa.

Authors:  M Kliner; A Knight; J Elston; C Humphreys; C Mamvura; J Wright; J Walley
Journal:  Public Health Action       Date:  2013-12-21

7.  The relevance of biopsy in tuberculosis patients without human immunodeficiency virus infection.

Authors:  Kyung Min Bae; Sung-Chul Lim; Hyung Ho Kim; Woo Jin Lee; Na Ra Yun; Choon-Mee Kim; Dong-Min Kim
Journal:  Am J Trop Med Hyg       Date:  2014-12-08       Impact factor: 2.345

8.  Primary tuberculosis of the thyroid gland: an unexpected cause of thyrotoxicosis.

Authors:  Lavanya Raman; James Murray; Rajesh Banka
Journal:  BMJ Case Rep       Date:  2014-02-27

9.  Infectious Complications After Liver Transplantation.

Authors:  Maria Del Pilar Hernandez; Paul Martin; Jacques Simkins
Journal:  Gastroenterol Hepatol (N Y)       Date:  2015-11

10.  Intranasal mucosal boosting with an adenovirus-vectored vaccine markedly enhances the protection of BCG-primed guinea pigs against pulmonary tuberculosis.

Authors:  Zhou Xing; Christine T McFarland; Jean-Michel Sallenave; Angelo Izzo; Jun Wang; David N McMurray
Journal:  PLoS One       Date:  2009-06-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.